Delivery Order SPE2DE24D0013-SPE2D625F4CNY
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $2,723.58 by the Defense Department's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 12, 2025. The contract, which carries no set-aside designation, represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicles with the Department of Veterans Affairs. Cepheid specializes in advanced...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $2,208 firm fixed-price delivery order (Contract No. XPRSTREPA-10) by the Medical Supply Chain, a Defense agency component, with a completion deadline of October 3, 2025. This delivery order was issued without a set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award falls under Cepheid's existing federal contracting relationship with defense...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,539.30 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order does not utilize a set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies to federal healthcare systems. The contract will be performed in...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, received a $6,800 firm fixed-price delivery order (XPRS4PLEX-10) from the Defense Department's Medical Supply Chain on August 22, 2025, with an ultimate completion date of August 29, 2025. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies and test kits to federal defense and healthcare systems. This...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,686.72 by the Defense Logistics Agency's Medical Supply Chain division on September 15, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order represents a purchase under an existing contract vehicle and carries no set-aside designation. Cepheid specializes in advanced diagnostic systems and test kits for infectious...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, has been awarded a delivery order valued at $2,040 under contract XPRS4PLEX-10 by the Medical Supply Chain, a defense-focused federal agency. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 18, 2025, carries no set-aside designation. The work will be performed in Sunnyvale, California, and represents a continuation of Cepheid's ongoing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $31,775.10 by the Defense Department's Medical Supply Chain organization on April 24, 2025. The contract, designated XPRSMVP-10, has an ultimate completion date of May 1, 2025 and carries no set-aside designation. The work will be performed at Cepheid's Sunnyvale facility. This delivery order falls under one of Cepheid's larger Indefinite Delivery...
- Cepheid, a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, has been awarded a delivery order valued at $8,533.57 under contract XPRS4PLEX-10 by the Medical Supply Chain, a Defense agency entity. The award, issued on August 29, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed-price pricing and does not include a set-aside designation. Performance will be conducted at Cepheid's Sunnyvale facility. This delivery order represents...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $13,600 by the Medical Supply Chain, a defense-oriented federal agency, on June 2, 2025. The contract, designated as XPRS4PLEX-10 with completion scheduled for June 9, 2025, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale. This delivery order represents a discrete procurement action within Cepheid's broader...
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 on September 10, 2025, by the Medical Supply Chain, a defense-focused federal agency. This delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, is associated with Cepheid's larger Indefinite Delivery Vehicle (IDV) contract with the Veterans Affairs Veterans Integrated Service Network 21, valued at $2.5...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F4CNYDelivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $6,544 firm fixed-price delivery order by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of October 1, 2025. The contract (4569580744 | XPRS4PLEX-10) carries no set-aside designation and represents a discrete purchase order under Cepheid's existing procurement relationship with the federal government. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing, with extensive experience delivering molecular diagnostic technologies to multiple federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, and Defense Logistics Agency. This delivery order aligns with Cepheid's core business supporting federal diagnostic needs and likely involves procurement of diagnostic equipment, reagents, test kits, or associated maintenance services for pathogen detection. The award reflects Cepheid's competitive positioning in the federal molecular diagnostics marketplace, where the company maintains two significant Indefinite Delivery Vehicles with the VA's Veterans Integrated Service Networks valued at approximately $35.3 million collectively. These overarching contracts enable continuous procurement of molecular diagnostic solutions, with the delivery order structure allowing the government to access Cepheid's GeneXpert systems and testing capabilities for conditions including COVID-19, influenza, RSV, and other infectious diseases across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 9/24/25 |